- Imatinib mesylate (Gleevec) in advanced breast cancer-expressing C-Kit or PDGFR-beta: clinical activity and biological correlations. Cristofanilli, M., Morandi, P., Krishnamurthy, S., Reuben, J.M., Lee, B.N., Francis, D., Booser, D.J., Green, M.C., Arun, B.K., Pusztai, L., Lopez, A., Islam, R., Valero, V., Hortobagyi, G.N. Ann. Oncol. (2008)